November 2017

Does Sci-fi Predict Future Tech?

Gavin Miller, Senior Lecturer in Medical Humanities and the University of Glasgow, shares his thoughts on whether science fiction can be used as a guidepost about future biomedical technologies.

Formulating the Future

A Spotlight Interview with... Kishor Wasan, Dean of the College of Pharmacy and Nutrition, University of Saskatchewan, Canada.

Formulation Best Practice

Are you in need of know-how about formulation best practices? In this technical roundtable, industry gurus Frank Romanski, Derek Bush and Kishor Wasan share their views and tips for success.

Technological Disruption

Print Possibilities

The FDA Abroad

FDA partners with EU authorities for pharma inspections

Pharma Firms Face Terrorism Suit

Iraq war victims have accused several companies of aiding and abetting terrorists

Leading the Way with Lipids

Complexity and Collaboration

Formulation continues to challenge the industry, but collaboration and new technologies can tackle the issues head on

Let Data Be Your Guide

Interest in new immunotherapies is increasing, but with complex drugs come complex analytical challenges. SPR-based systems can provide high-quality molecular interaction data to guide biotherapeutic development – from target selection to final QC.

Where Are We Going?

Joe Flower is a healthcare futurist who has built a career around helping companies prepare for the future. Here, he shares where healthcare and pharma should head, if we want to avoid a dystopia.

Single-Use That’s Ready When You Are

Biopharma has embraced the benefits of single-use, but with a growing number of available components and highly customized assemblies, the supply chain becomes quite complex. Merck KGaA has designed a new program offering customized single-use assemblies.Biopharma has embraced the benefits of single-use, but the supply chain becomes quite complex. MilliporeSigmahas designed a new program offering customized single-use assemblies with reduced lead times, and an enhanced level of supply security.

A Media Match Made in Heaven

When it comes to a good cell culture media, biopharma manufacturers desire a chemically defined formula, controlled variance and, increasingly, a specific protein quality profile.When it comes to a good cell culture media, biopharma manufacturers desire a chemically defined formula, controlled variance and, increasingly, a specific protein quality profile.

Intelligent Drug Discovery

One technology likely to play a role in pharma’s future is AI. Artificial intelligence is already being explored as a means towards making better informed decisions, generating new hypotheses and repurposing failed drug candidates.

Exploring Pharma’s Far Future

Will healthcare and pharma in the year 2100 feel like utopia or dystopia? And why should we care, when we won’t be around to see it? In short, the foundations for a sustainable future need to be laid now.

Addressing Protein Aggregation

The formation of protein aggregates in biopharmaceuticals can be difficult to predict and control. Here’s how we can improve patient safety through primary packaging materials and bedside filtration.

Melt in the Mouth

Orally disintegrating tablets are winning patients over thanks to ease of use, but manufacture is unconventional, which raises a number of challenges and the need for careful consideration.

Coming in From the Cold

Lyophilization has changed little over the last 75 years, and the pharmaceutical industry has struggled to address the known inefficiencies of this old technology. Now, a new consortium has been founded to provide a risk-free environment to help advance lyophilization instruments and processes. Is freeze-drying finally heating up?

On a (Public Health) Mission

Sitting Down With… Margaret Hamburg, President-elect, American Association for the Advancement of Science (AAAS); and Foreign Secretary, National Academy of Medicine.

Believe in RNAi

The gates for gene and cell therapies are open – and RNAi technology could be a serious contender for the therapy of the future.

Winter is Coming

Cyber attacks are an increasing threat for all industries – so pharma needs to ensure its security measures are up to scratch.

Gut Feeling

Can the microbiome predict the likelihood of chemotherapy side effects?

Learning from Failure

Cardiovascular toxicity often hinders success – are companies picking the wrong compounds?

Mini Mimic

Body-on-a-chip technology aims to streamline drug development and further personalize medicine

Steady On, Pharma

Pharma’s 2022 growth forecast has been reduced for the first time in a decade

Business-in-Brief

Expediting generics, the age of digital manufacture, and coping with API violations… What’s new for pharma in business?

Brexit Update: Calls for Customs Clarity

The EFPIA highlights the risks of disrupting UK–EU medicine supply chains

Big Brother is Monitoring Your Adherence

What does FDA approval of a pill that tracks drug compliance mean for privacy?